Dark

Check out our Dark Pool Levels

GTH
Genetron Holdings Limited ADS
stock NASDAQ

Inactive

Mar 28, 2024

4.03USD+0.124%(+0.01)412,603

Pre-market

0.00USD-100.000%(-4.02)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 31, 2022

08:00AM EST Genetron Holdings Limited (Genetron Health or the Company, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that management will be participating in two upcoming virtual investor conferences. GlobeNewswire Inc

Jan 10, 2022

06:20AM EST Genetron Expects 2021 Revenue To Be Around RMB 530 Mln RTTNews

06:00AM EST Genetron Health Reiterates Full Year 2021 Revenue Guidance GlobeNewswire Inc

Jan 5, 2022

11:07AM EST Stocks That Hit 52-Week Lows On Wednesday Benzinga

Dec 13, 2021

01:30AM EST Genetron Healths Social Contribution Campaign to GlobeNewswire Inc

Nov 30, 2021

04:39PM EST Genetron Health Announced Late Monday, A Co-Development Agreement with AstraZeneca R&D China for Personalized MRD Tests for Solid Tumors in China Benzinga

04:39PM EST Earnings Scheduled For November 30, 2021 Benzinga

05:00AM EST Genetron Holdings Limited (Genetron Health or the Company, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today reported its unaudited preliminary financial results for the third quarter ended September30, 2021. GlobeNewswire Inc

Nov 29, 2021

10:00PM EST Genetron Health Announces Co-Development Agreement with GlobeNewswire Inc

Nov 16, 2021

05:09AM EST Genetron Health Announced Release of Two Cancer Research Study Results at the Association for Molecular Pathology 2021 Annual Meeting Benzinga

05:00AM EST Genetron Health Reveals Two Cancer Research Study Results at the GlobeNewswire Inc

Nov 15, 2021

08:00AM EST Genetron Health to Participate in the 8th BioCentury-BayHelix GlobeNewswire Inc

05:00AM EST Genetron Health Announces Publication of Enhanced Variant Caller GlobeNewswire Inc

Nov 8, 2021

11:36AM EST Genetron Early Monday Reported Entered Strategic Partnership With NeoGenomics To Drive Global Oncology Drug Research, Development Benzinga

05:00AM EST Genetron Health Establishes Strategic Partnership with NeoGenomics GlobeNewswire Inc

Nov 4, 2021

06:47AM EDT Genetron Health's Multi-Gene Mutation Detection Kit Onco PanScan Obtains CE Mark Benzinga

06:00AM EDT Genetron Healths Multi-Gene Mutation Detection GlobeNewswire Inc

Nov 3, 2021

02:00AM EDT Genetron Health Wins Second Prize of Chinas GlobeNewswire Inc

Oct 22, 2021

07:22AM EDT Genetron Health, Fosun Pharma Partner To Commercialize Seq-MRD In China RTTNews

07:10AM EDT Genetron Health And Fosun Pharma Announce Exclusive Partnership To Commercialize Seq-MRD In China; Financial Details Not Disclosed Benzinga

07:00AM EDT Genetron Health and Fosun Pharma Announce Exclusive Partnership to GlobeNewswire Inc

Oct 4, 2021

11:49AM EDT Overview Of Value Stocks In The Healthcare Sector Benzinga

Sep 27, 2021

10:25AM EDT Genetron Health, IMPACT Therapeutics Join Forces For Synthetic Inhibitors For Cancer Applications Benzinga

06:05AM EDT Genetron Health And IMPACT Therapeutics Announce Partnership To Drive Development of Synthetic Lethal Product Pipeline Benzinga

06:00AM EDT Genetron Health and IMPACT Therapeutics Announce Partnership to GlobeNewswire Inc

Sep 16, 2021

06:00AM EDT Genetron Health Unveils 13 Cancer Research findings at ESMO GlobeNewswire Inc

Sep 3, 2021

11:07AM EDT Genetron Added to FTSE Russell Global Equity Index Series Benzinga

11:07AM EDT Genetron Holdings Limited (Genetron Health or the Company, NASDAQ: GTH), today announced that Genetron will be added to the below FTSE Global Equity Index Series ("GEIS"), following FTSE's most recent quarterly review. These inclusions will become effective after the market close on Friday, September 17, 2021: GlobeNewswire Inc

Aug 30, 2021

06:00AM EDT Genetron Healths Co-Founder and Chief Scientific GlobeNewswire Inc

Aug 24, 2021

08:12AM EDT Genetron Holdings: Q2 Earnings Insights Benzinga

07:26AM EDT Genetron Holdings Q2 EPS $(0.03) Up From $(0.19) YoY, Sales $21.80M Up From $14.40M YoY Benzinga

07:23AM EDT Genetron Holdings Limited (Genetron Health or the Company, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced its unaudited preliminary financial results for the second quarter ended June30, 2021. GlobeNewswire Inc

04:29AM EDT Earnings Scheduled For August 24, 2021 Benzinga

Aug 23, 2021

05:00PM EDT Genetron Health to Host Calls Following Earnings and Participate GlobeNewswire Inc

07:00AM EDT Genetron Health Reaches Strategic Partnership with Yikon Genomics, GlobeNewswire Inc

Aug 11, 2021

08:00AM EDT Genetron Health to Announce Second Quarter 2021 Financial Results GlobeNewswire Inc

07:22AM EDT Genetron Health Tops NCCLs External Quality GlobeNewswire Inc

Jul 29, 2021

04:35AM EDT Genetron Health Partners with Guizhou Provinces GlobeNewswire Inc

Jul 26, 2021

06:10AM EDT Genetron Holdings Announces Its AYVAKIT Has Entered Priority Review And Approval Process In China Benzinga

06:00AM EDT Genetron Holdings Limited (Genetron Health or the Company, NASDAQ: GTH), today announced that its AYVAKIT (avapritinib) companion diagnostic (CDx) kit, developed in partnership with CStone Pharmaceuticals (CStone, HKEX: 2616) has entered the priority review and approval process under the National Medical Products Administration (NMPA) in China. GlobeNewswire Inc

Jul 13, 2021

08:32AM EDT Genetron Health Says Receives CE Mark For 8-Gene Lung Cancer Assay, Provides FDA Reference Panel Comparative Data Of Its SARS-CoV-2 RNA Test Benzinga

08:32AM EDT Genetron Health Receives CE Mark for 8-Gene Lung Cancer Assay and GlobeNewswire Inc

Jul 1, 2021

10:00PM EDT Genetron Holdings Limited (Genetron Health or the Company, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, announced a new partnership with the World Economic Forum (WEF), under its Health and Healthcare Platform. GlobeNewswire Inc

Jun 4, 2021

06:00AM EDT Genetron Holdings Limited (Genetron Health or the Company, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced the release of 16 research results at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. GlobeNewswire Inc

May 24, 2021

06:04AM EDT Genetron Q1 Total Revenue Up 19.8% To RMB 92.1 Mln Or $14.1 Mln From RMB 76.8 Mln Last Year RTTNews

06:02AM EDT Genetron Holdings Q1 Earnings Per ADS $(0.19) Misses $(0.18) Estimate, Sales $14.05M Miss $14.21M Estimate Benzinga

06:00AM EDT Genetron Holdings Limited (Genetron Health or the Company, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced its unaudited preliminary financial results for the first quarter ended March31, 2021. GlobeNewswire Inc

04:00AM EDT Earnings Scheduled For May 24, 2021 Benzinga

May 20, 2021

06:18AM EDT Genetron Health Announces Strategic Partnership with JD Health to Create Innovative Solutions for Full-cycle Cancer Management Benzinga

06:16AM EDT Genetron Health Announces Strategic Partnership with JD Health to GlobeNewswire Inc

May 13, 2021

06:23AM EDT Genetron Health Announces Strategic Partnership With Siemens Healthineers To Promote Precision Oncology For Lung Cancer RTTNews

May 10, 2021

07:00AM EDT TellBio Unveils Next-Generation Liquid Biopsy Platform Focused on GlobeNewswire Inc

May 3, 2021

05:00PM EDT Genetron Health to Announce First Quarter 2021 Financial Results GlobeNewswire Inc

Apr 13, 2021

01:36AM EDT Genetron Health Releases 22 New Research Results At AACR 2021 RTTNews

01:31AM EDT Genetron Health Releases 22 New Research Results at American Association for Cancer Research Annual Meeting (AACR) 2021 Business Wire

Apr 1, 2021

06:00PM EDT Genetron Health to Present at the SVB Leerink CybeRx Series: GlobeNewswire Inc

06:39AM EDT Genetron Health Presented Its Proprietary Early Screening Technology Mutation Capsule at Science/AAAS Webinar Business Wire

Mar 25, 2021

07:58AM EDT The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut Benzinga

06:54AM EDT Genetron Health FY Non-IFRS Loss RMB 215.7 Mln Or $33.1 Mln; Operating Loss RMB 268.4 Mln Or $41.1 Mln RTTNews

06:49AM EDT Genetron Holdings Q4 ADS (0.12), EPS $(0.02) Beats $(0.11) Estimate, Sales $20.50M Beat $20.16M Estimate Benzinga

06:47AM EDT Genetron Health Reports Unaudited Fourth Quarter and Full Year 2020 Financial Results, and Provides 2021 Revenue Guidance Business Wire

04:03AM EDT Earnings Scheduled For March 25, 2021 Benzinga

Mar 24, 2021

05:03PM EDT Genetron Holdings Says HCCscreen Achieved 88% Sensitivity, 93% Specificity Compared With 71% And 95% respectively By Ultrasound Plus AFP Benzinga

05:00PM EDT Genetron Health Releases New Data Results of HCCscreen(tm) for Liver Cancer Early Screening in China Business Wire

Mar 17, 2021

04:30PM EDT Genetron Health to Participate at Credit Suisse Asian Investment Conference on Mar. 26th, 2021 Business Wire

Mar 15, 2021

06:24AM EDT Genetron Health to Present at Science/AAAS Webinar About Early Cancer Screening on March 31 Business Wire

Mar 4, 2021

05:00PM EST Genetron Health to Announce Fourth Quarter and Full Year 2020 Unaudited Financial Results and Host Investor Call on March 25, 2021 Business Wire

Feb 17, 2021

07:27AM EST The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal Benzinga

Feb 11, 2021

11:21AM EST Stocks That Hit 52-Week Highs On Thursday Benzinga

Feb 9, 2021

08:10AM EST The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement Benzinga

07:00AM EST Genetron Health's Early Liver Cancer Screening Research Results Included in First Prevention and Treatment Guidelines for Patients in China Business Wire

Jan 27, 2021

05:00AM EST Genetron Health to Release Thirteen Research Findings at 21st World Conference on Lung Cancer Business Wire

Jan 21, 2021

08:05AM EST The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping Benzinga

Jan 20, 2021

07:32AM EST The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study Benzinga

Jan 15, 2021

07:57AM EST The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges Benzinga

Jan 14, 2021

07:57AM EST The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates Benzinga

Jan 13, 2021

07:25AM EST The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations Benzinga

06:30AM EST Genetron Health to Present at BTIG Early Cancer Screening, Diagnostics Reimbursement and Genomic Tools KOL Day on Jan. 22, 2021 Business Wire

Jan 6, 2021

10:07AM EST Shares of Genetron Holdings Ltd. (GTH) are rising over 24%, after the company announced an exclusive strategic partnership agreement with Chia Tai Tianqing Pharmaceutical Group Co. Ltd., a subsidiary of Sino Biopharmaceutical Ltd., for HCCscreen, Genetron Health's blood-based early screening test for hepatocellular carcinoma or HCC in China. RTTNews

05:26AM EST Genetron Health Announced Exclusive Strategic Partnership with Sino Biopharm Subsidiary for HCCscreen Test for Hepatocellular Carcinoma in China Benzinga

04:48AM EST Genetron Holdings And CTTQ Announce Exclusive Strategic Partnership Agreement For HCCscreen RTTNews

04:40AM EST Genetron Health Announces Exclusive Strategic Partnership with Sino Biopharm Subsidiary for HCCscreen(tm) in China Business Wire

Nov 27, 2020

08:36AM EST Genetron Holdings Limited (GTH) on Friday provided an update for HCCscreen, its blood-based early screening test for hepatocellular carcinoma or HCC in China. RTTNews

08:11AM EST Genetron Holdings Provides Update For HCCscreen, Its Blood-based Early Screening Test For HCC, In China RTTNews

08:04AM EST Genetron Reports HCCscreen Was Selected By National Cancer Center, Wuxi Municipal Gov't. For Use In 'Liver Cancer Early Screening Comprehensive Prevention and Control Project' Benzinga

08:00AM EST Genetron Health Provides Update on HCCscreen(tm) for Liver Cancer Early Screening in China Business Wire

Nov 20, 2020

06:00AM EST COVID-19 Highlights Role of Early Detection in Fighting Threatening Diseases, Especially Cancer, Genetron CEO Tells CNBC Conference Business Wire

Nov 19, 2020

09:53AM EST Genetron Health Named One of the "50 Smartest Companies in China 2020" by MIT Technology Review Business Wire

Nov 12, 2020

05:30AM EST Genetron Health to Present at CNBC East Tech West Conference GlobeNewswire Inc

Nov 9, 2020

06:32AM EST Genetron Holdings Q3 EPS $(0.01) Beats $(0.10) Estimate, Sales $16.49M Beat $16.13M Estimate Benzinga

06:30AM EST Genetron Health Reports Third Quarter 2020 Unaudited Financial GlobeNewswire Inc

04:13AM EST Earnings Scheduled For November 9, 2020 Benzinga

Oct 29, 2020

08:00AM EDT Genetron Holdings Limited (Genetron Health or the Company, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that management will present and host 1x1 investor meetings at six upcoming investor and industry conferences. GlobeNewswire Inc

Oct 26, 2020

08:01AM EDT Genetron Health to Announce Third Quarter Unaudited Financial GlobeNewswire Inc

Oct 22, 2020

06:16AM EDT Genetron Health Enters Exclusive Global Licensing Agreement with ImmuQuad Biotechnologies to Develop and Commercialize Minimal Residual Disease Assays in Hematologic Cancer Benzinga

06:00AM EDT Genetron Health Enters Exclusive Global Licensing Agreement with GlobeNewswire Inc

Sep 30, 2020

03:55PM EDT Mid-Afternoon Market Update: Dow Jumps 350 Points; Iterum Therapeutics Shares Spike Higher Benzinga

08:14AM EDT Genetron Health Receives US FDA Breakthrough Device Designation For its Blood-Based NGS Test For Early Detection Of Hepatocellular Carcinoma Benzinga

08:11AM EDT Genetron Health Receives U.S. FDA Breakthrough Device Designation GlobeNewswire Inc

Sep 25, 2020

06:06AM EDT Genetron Health, CStone Pharma Launch Clinical Trial In China Of Avapritinib RTTNews

06:06AM EDT Genetron And CStone Launch Clinical Trial In China For Companion Diagnostic Test In Development For Avapritinib RTTNews

06:03AM EDT Genetron Reports Launch Of Trial In China For Companion Diagnostic Test In Development For Avapritinib For Detection Of 'D842V mutation in the human platelet-derived growth factor receptor alpha (PDGFRA) gene' Benzinga

06:00AM EDT Genetron Health and CStone Pharmaceuticals Announce Launch of GlobeNewswire Inc

Sep 18, 2020

06:04AM EDT Genetron Reports Will Highlight Data From 18 Studies At European Society for Medical Oncology Congress September 19-21 Benzinga

06:00AM EDT Genetron Health to present data at ESMO 2020 relating to precision oncology diagnostic development initiatives across lung, gastrointestinal and other cancer types, and to bioinformatics development GlobeNewswire Inc

Sep 16, 2020

05:01PM EDT Genetron Health And dMed Announce Partnership Agreement; Terms Not Disclosed Benzinga

05:00PM EDT Genetron Health and dMed Announce Partnership Agreement GlobeNewswire Inc

Sep 8, 2020

04:15PM EDT Genetron Holdings Limited (Genetron Health or the Company, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, today announced that its executive management team will participate in the following conferences. GlobeNewswire Inc

Aug 29, 2020

10:33AM EDT Genetron Holdings Limited (Genetron Health or the Company, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests,today announced its participation in the launch of a major national research project for early screening of lung and digestive system cancers led by Chinas Ministry of Science and Technology (MOST). GlobeNewswire Inc

Aug 6, 2020

07:34AM EDT Genetron Holdings Q2 EPS $(0.19) Misses $(0.09) Estimate, Sales $14.40M Beat $14.19M Estimate Benzinga

06:30AM EDT Genetron Holdings Limited (Genetron Health or the Company) (Nasdaq: GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests, today announced its unaudited financial results for the second quarter ended June30, 2020. GlobeNewswire Inc

Jul 27, 2020

04:30PM EDT Genetron Holdings Limited (Genetron Health or the Company, NASDAQ:GTH), a leading precision oncology company in China that specializes in offering molecular profiling tests, today announced that it will report unaudited financial results for the second quarter ended June 30, 2020, on August 6, 2020, before the US market open. GlobeNewswire Inc

Jul 14, 2020

09:57AM EDT Benzinga's Top Upgrades, Downgrades For July 14, 2020 Benzinga

06:19AM EDT BTIG Initiates Coverage On Genetron Holdings with Buy Rating, Announces Price Target of $20 Benzinga

05:27AM EDT Canaccord Genuity Initiates Coverage On Genetron Holdings with Buy Rating, Announces Price Target of $19 Benzinga

Share